Prediction of prognosis of immune checkpoint inhibitors combined with anti-angiogenic agents for unresectable hepatocellular carcinoma by machine learning-based radiomics.
Xu X, Jiang X, Jiang H, Yuan X, Zhao M, Wang Y, Chen G, Li G, Duan Y
Xu X, Jiang X, Jiang H, Yuan X, Zhao M, Wang Y, Chen G, Li G, Duan Y
Kong C, Yan D, Liu K, Yin Y, Ma C
Arzani S, Soltani P, Karimi A, Yazdi M, Ayoub A, Khurshid Z, Galderisi D, Devlin H
He S, Deng B, Chen J, Li J, Wang X, Li G, Long S, Wan J, Zhang Y
Yan L, Xu J, Ye X, Lin M, Gong Y, Fang Y, Chen S
Zhou Y, Ye M, Ye H, Zeng S, Shu X, Pan Y, Wu A, Liu P, Zhang G, Cai S, Chen S
Yipeng Sun, Linda-Sophie Schneider, Chengze Ye, Mingxuan Gu, Siyuan Mei, Siming Bayer, Andreas Maier
Fan S, Xie J, Zheng S, Wang J, Zhang B, Zhang Z, Wang S, Cui Y, Liu J, Zheng X, Ye Z, Cui X, Yue D
Ni M, Jiesisibieke D, Zhao Y, Wang Q, Gao L, Tian C, Yuan H
Fiolet ATL, Lin A, Kwiecinski J, Tutein Nolthenius J, McElhinney P, Grodecki K, Kietselaer B, Opstal TS, Cornel JH, Knol RJ, Schaap J, Aarts RAHM, Tutein Nolthenius AMFA, Nidorf SM, Velthuis BK, Dey D, Mosterd A
Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.
We respect your privacy. Unsubscribe at any time.